Two weeks after Trump unveiled plan to lower drug prices, two cancer drugs got a $1,000-per-month price hike

Two weeks after President Trump in May unveiled a plan to lower drug prices for Americans, promising “it will start to take effect very soon,” the drug company Bayer hiked the list prices of two cancer drugs by more than $1,000 per month.